Point72 Asset Management’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

Point72 Asset Management’s Portfolio DCPH Stock Details DCPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-106,800	Closed	-$1.72M	–	2726
2023 Q4	$1.72M	Sell	106,800 -491,278	-82%	-$6.27M	﹤0.01%	1254
2023 Q3	$7.61M	Sell	598,078 -20,868	-3%	-$288K	0.02%	745
2023 Q2	$8.71M	Buy	618,946 +544,995	+737%	+$7.8M	0.03%	632
2023 Q1	$1.14M	Buy	+73,951	New	+$1.23M	﹤0.01%	1082
2021 Q4	–	Sell	-50,926	Closed	-$1.73M	–	1363
2021 Q3	$1.73M	Sell	50,926 -115,174	-69%	-$3.68M	0.01%	794
2021 Q2	$6.08M	Buy	+166,100	New	+$6.43M	0.03%	571
2020 Q1	–	Sell	-181,680	Closed	-$11.3M	–	1149
2019 Q4	$11.3M	Sell	181,680 -134,421	-43%	-$6.39M	0.06%	358
2019 Q3	$10.7M	Buy	316,101 +111,827	+55%	+$3.31M	0.07%	349
2019 Q2	$4.61M	Buy	+204,274	New	+$4.78M	0.02%	533
2019 Q1	–	Sell	-300,000	Closed	-$6.3M	–	1281
2018 Q4	$6.3M	Buy	+300,000	New	+$7.38M	0.03%	504

Other funds holding DCPH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

PCH

Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return

Point72 Asset Management's DCPH Position: Q1 2024 in Review

Point72 Asset Management sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q1 2024, closing a stake of 106,800 shares — an estimated $1.72M sold.

Point72 Asset Management first reported a position in DCPH in Q4 2018 and held it in 10 quarters. The position peaked at $11.3M in Q4 2019. 177 funds tracked by Wall St. Rank hold DCPH as of Q1 2024.

Point72 Asset Management reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Point72 Asset Management sold 106,800 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q1 2024, an estimated $1.72M.
Point72 Asset Management first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q4 2018 and held it in 10 quarters.
Point72 Asset Management's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $11.3M in Q4 2019.
177 funds tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q1 2024.

Based on Point72 Asset Management's 13F filing for Q1 2024, filed 15 May 2024.